In this episode of From the Wire, Paradigm Biopharmaceuticals' founder and MD Paul Rennie sits down with senior markets reporter Jonathon Davidson to discuss how he got into the sector, the lessons he took early on in his career, Paradigm's early days, what exactly the company is targeting now, and plenty more.

This content is disseminated in partnership with Paradigm Biopharmaceuticals Ltd. It is intended to inform investors and should not be taken as a recommendation or financial advice.

The material in this podcast is for information only and should not be treated as investment advice. Listeners are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions.

For HotCopper's full disclaimer, please ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠click here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.